...
首页> 外文期刊>Journal of Clinical and Diagnostic Research >The Immunohistochemical Expression of the Oestrogen Receptor (ER), HER-2e u and Cytokeratin 8/18 and 5/6 in InvasiveBreast Carcinoma
【24h】

The Immunohistochemical Expression of the Oestrogen Receptor (ER), HER-2e u and Cytokeratin 8/18 and 5/6 in InvasiveBreast Carcinoma

机译:侵袭性乳腺癌中雌激素受体(ER),HER-2 / ne u和细胞角蛋白8/18和5/6的免疫组织化学表达

获取原文

摘要

An immunohistochemical study was done on 39 cases of invasive breast carcinoma for further sub-classification, for predicting their prognosis and therapeutic approaches. These cases were evaluated for the expression of cytokeratin Ck 8/18, ER and Her-2eu and 28 cases were subjected to the evaluation of cytokeratin Ck 5/6, which especially included the cases which were negative for all the three markers. ER was positive in 7 cases, with Her-2eu being positive in 8 cases and cytokeratin 8/18 being positive in 33 cases. Cytokeratin 5/6 was positive in 7 cases, with 4 cases showing Ck 5/6 and Ck8/18 positivity, 3 cases showing positivity for Ck 5/6 only and 3cases showing negativity for all the 4 markers. Thus they were classified as the luminal A, luminal B, combined, basal and the null types respectively.
机译:对39例浸润性乳腺癌进行了免疫组织化学研究,以进一步分类,以预测其预后和治疗方法。对这些病例的细胞角蛋白Ck 8/18,ER和Her-2 / neu的表达进行了评估,并且对28例细胞角蛋白Ck 5/6的表达进行了评估,其中特别包括对所有三种标记物均为阴性的病例。 ER阳性7例,Her-2 / neu阳性8例,细胞角蛋白8/18阳性33例。细胞角蛋白5/6阳性7例,其中4例显示Ck 5/6和Ck8 / 18阳性,3例仅显示Ck 5/6阳性,3例显示所有4种标记物均为阴性。因此,它们分别被分类为腔A,腔B,组合型,基础型和无效型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号